Global – Pfizer hosted its second annual AI Festival Week, bringing together colleagues worldwide to explore the transformative potential of artificial intelligence in healthcare and scientific research. The festival featured 54 sessions across seven countries, including hands-on labs, panel discussions, and fireside chats with leading AI experts.
The event highlighted how AI is accelerating drug discovery, improving patient care, and streamlining workflows across the company. Participants engaged in practical workshops, including No-Code Agent labs, and explored ways to integrate AI into daily operations to increase efficiency and drive innovation.
Key discussions emphasized the importance of high-quality data as the foundation of successful AI applications. Fireside chats with industry leaders explored how AI can augment human creativity, enhance clinical documentation, and improve the precision of healthcare delivery while maintaining safety and regulatory compliance.
Pfizer executives stressed that AI adoption requires not just technology, but a cultural shift toward experimentation, collaboration, and continuous learning. The festival encouraged colleagues to embrace AI as a tool that creates new opportunities, elevates existing roles, and enhances patient-focused outcomes.
“Pfizer’s AI Festival is about more than technology; it’s about empowering our teams to harness AI responsibly and effectively,” said Berta Rodriguez Hervas, Chief AI and Analytics Officer at Pfizer. “Through innovation and collaboration, we can accelerate breakthroughs that improve the lives of patients worldwide.”
The AI Festival also explored the role of open-source AI models, smaller, efficient AI systems, and human-in-the-loop approaches to ensure accuracy, adaptability, and operational excellence across healthcare and pharmaceutical operations.
Pfizer continues to invest in AI as a strategic enabler of scientific progress, underscoring its commitment to innovation and patient impact.
About Pfizer
Pfizer is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines and vaccines that improve patient outcomes. Its work spans oncology, immunology, neuroscience, vaccines, and rare diseases, reaching millions of patients around the world.
For more information, visit www.pfizer.com.
By